Keywords: profits, increase, mitsubishi, pharma, corp, created, through
Profits increase at Mitsubishi Pharma
Article | 28 November 2001
Mitsubishi Pharma Corp, created through the merger of Mitsubishi-TokyoPharmaceuticals and Welfide Corp (Marketletters passim), has posted a 3.3% decline in sales ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- US Supreme Court says patent settlement can "sometimes" be illegal
- Actavis and Kissei file law suits against Sandoz and Hetero over Rapaflo patent
